menu close
close
News

Prof. Härtl (Psychology School am Standort München) veröffentlicht einen Artikel in der renommierten internationalen Fachzeitschrift The Breast

Schwentner, L., Härtl, K. et al. (2016). Short term quality of life with epirubicin-fluorouracil- cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer – Results from the prospective multi- center randomized ADEBAR trial, The Breast, 27, 69-77.

Tags: